Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes (R-KAT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2014 by St. Michael's Hospital, Toronto.
Recruitment status was  Recruiting
Canadian Diabetes Association
Information provided by (Responsible Party):
Vladimir Vuksan, St. Michael's Hospital, Toronto Identifier:
First received: April 12, 2012
Last updated: February 18, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)